Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pueraria candollei var. mirifica is a medicinal plant native to Thailand, widely known in traditional medicine as "Kwao Krua" or "White Kwao Krua," and used for rejuvenation and relief of menopausal symptoms. Its tuber contains high concentrations of phytoestrogens, primarily miroestrol, deoxymiroestrol, puerarin, daidzein, daidzin, genistein, and other related compounds. These phytoestrogens exhibit estrogenic activity, preferentially binding to estrogen receptor beta (ERβ) and modulating gene expression in target tissues. Mechanistic studies show in vitro and animal models evidence for estrogen receptor agonism, antioxidant activity, potential bone protective effects, and mild neuroprotective effects. Clinical studies for postmenopausal symptom management show reduced hot flashes, improved urogenital symptoms, and reduced bone turnover, but results are inconclusive and further study is needed. Pueraria candollei var. mirifica is not approved as a pharmaceutical and is widely marketed as a dietary supplement for menopause relief and general rejuvenation[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pueraria candollei var. mirifica.